Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseasesNathan A. Berger, Csaba Szabó, Solomon H. Snyder et al.|British Journal of Pharmacology|2017Cited by 210
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationJae Kyu Ryu, Katerina Akassoglou, Victoria A. Rafalski et al.|Nature Immunology|2018Cited by 210
Hypoglycemic Neuronal Death and Cognitive Impairment Are Prevented by Poly(ADP-Ribose) Polymerase Inhibitors Administered after HypoglycemiaSang Won Suh, Raymond A. Swanson|Journal of Neuroscience|2003Cited by 206
Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 ExpressionCarole Escartin, Raymond A. Swanson|Journal of Neuroscience|2011Cited by 96
Brain energy metabolism: A roadmap for future researchCaroline Rae, Mary C. McKenna, Joseph A. Baur et al.|Journal of Neurochemistry|2024Cited by 94